[Role of ranitidine in the treatment and prevention of NSAID-induced digestive lesions].
Bommelaer
G
G
Service d'hépatogastroentérologie, Hôtel-Dieu, Clermont-Ferrand.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004382:Duodenitis / Q000139:chemically induced / Q000517:prevention & control; D005756:Gastritis / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D016595:Misoprostol / Q000627:therapeutic use; D054328:Proton Pump Inhibitors; D011899:Ranitidine / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D016595:Misoprostol; D011899:Ranitidine